Literature DB >> 12598623

Target-derived trophic effect on skeletal muscle innervation in senescent mice.

Maria Laura Messi1, Osvaldo Delbono.   

Abstract

In the present work, we tested the hypothesis that target-derived insulin-like growth factor-1 (IGF-1) prevents alterations in neuromuscular innervation in aging mammals. To explore this hypothesis, we studied senescent wild-type mice as a model of deficient IGF-1 secretion and signaling and S1S2 transgenic mice as a tool to investigate the role of sustained overexpression of IGF-1 in striated muscle in neuromuscular innervation. The analysis of the nerve terminal in extensor digitorum longus muscles from senescent mice showed that the decrease in the percentage of cholinesterase-stained zones (CSZ) exhibiting nerve terminal branching, number of nerve branches at the CSZ, and nerve branch points was partially or completely reversed by sustained overexpression of IGF-1 in skeletal muscle. Target-derived IGF-1 also prevented age-related decreases in the postterminal alpha-bungarotoxin immunostained area, as well as the reduction in the number and length of postsynaptic folds, and area and density of postsynaptic folds studied with electron microscopy. Overexpression of IGF-1 in skeletal muscle may account for the lack of age-dependent switch in muscle fiber type composition recorded in senescent mice. In summary, the use of the S1S2 IGF-1 transgenic mouse model allowed us to provide morphological evidence for the role of target-derived IGF-1 in spinal cord motor neurons in senescent mice.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12598623      PMCID: PMC6742258     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  25 in total

Review 1.  Insulin-like growth factors in the peripheral nervous system.

Authors:  Kelli A Sullivan; Bhumsoo Kim; Eva L Feldman
Journal:  Endocrinology       Date:  2008-08-21       Impact factor: 4.736

2.  Motor neuron targeting of IGF-1 attenuates age-related external Ca2+-dependent skeletal muscle contraction in senescent mice.

Authors:  Anthony M Payne; María Laura Messi; Zhenlin Zheng; Osvaldo Delbono
Journal:  Exp Gerontol       Date:  2006-12-14       Impact factor: 4.032

3.  Motor neurone targeting of IGF-1 prevents specific force decline in ageing mouse muscle.

Authors:  Anthony M Payne; Zhenlin Zheng; María Laura Messi; Carol E Milligan; Estela González; Osvaldo Delbono
Journal:  J Physiol       Date:  2005-11-17       Impact factor: 5.182

4.  Does insulin-like growth factor 1 genotype influence muscle power response to strength training in older men and women?

Authors:  Suchi Sood; Erik D Hanson; Matthew J Delmonico; Matthew C Kostek; Brian D Hand; Stephen M Roth; Ben F Hurley
Journal:  Eur J Appl Physiol       Date:  2011-06-11       Impact factor: 3.078

Review 5.  Mechanisms of Muscle Denervation in Aging: Insights from a Mouse Model of Amyotrophic Lateral Sclerosis.

Authors:  Kevin H J Park
Journal:  Aging Dis       Date:  2015-10-01       Impact factor: 6.745

Review 6.  Insulin-like growth factor 1 physiology: lessons from mouse models.

Authors:  Shoshana Yakar; Martin L Adamo
Journal:  Endocrinol Metab Clin North Am       Date:  2012-05-15       Impact factor: 4.741

7.  Profiling age-related muscle weakness and wasting: neuromuscular junction transmission as a driver of age-related physical decline.

Authors:  Carlos J Padilla; Markus E Harrigan; Hallie Harris; Jan M Schwab; Seward B Rutkove; Mark M Rich; Brian C Clark; W David Arnold
Journal:  Geroscience       Date:  2021-04-24       Impact factor: 7.713

8.  Sarcoglycan Alpha Mitigates Neuromuscular Junction Decline in Aged Mice by Stabilizing LRP4.

Authors:  Kai Zhao; Chengyong Shen; Lei Li; Haitao Wu; Guanglin Xing; Zhaoqi Dong; Hongyang Jing; Wenbing Chen; Hongsheng Zhang; Zhibing Tan; Jinxiu Pan; Lei Xiong; Hongsheng Wang; Wanpeng Cui; Xiang-Dong Sun; Shihua Li; Xinping Huang; Wen-Cheng Xiong; Lin Mei
Journal:  J Neurosci       Date:  2018-08-31       Impact factor: 6.167

9.  The lack of effect of specific overexpression of IGF-1 in the central nervous system or skeletal muscle on pathophysiology in the G93A SOD-1 mouse model of ALS.

Authors:  Maria Laura Messi; Heather M Clark; David M Prevette; Ronald W Oppenheim; Osvaldo Delbono
Journal:  Exp Neurol       Date:  2007-06-02       Impact factor: 5.330

Review 10.  Sarcopenia: etiology, clinical consequences, intervention, and assessment.

Authors:  T Lang; T Streeper; P Cawthon; K Baldwin; D R Taaffe; T B Harris
Journal:  Osteoporos Int       Date:  2009-09-25       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.